Sites and mechanisms of localization of technetium 99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues

L. M. Buja, A. J. Tofe, P. V. Kulkarni, A. Mukherjee, R. W. Parkey, M. D. Francis, F. J. Bonte, J. T. Willerson

Research output: Contribution to journalArticlepeer-review

144 Scopus citations

Abstract

This study was performed to elucidate the localization at the cellular level of technetium-99m phosphorus (99(m)Tc-P) radiopharmaceuticals in acute myocardial infarcts and the mechanisms responsible for 99(m)Tc-P uptake in acute myocardial infarcts and other tissues. In 20 dogs with proximal left anterior descending coronary arterial ligation for 1-3 days, elevated calcium levels were measured at all sites of increased 99(m)Tc-P uptake (acute myocardial infarcts, necrotic thoracotomy muscle, lactating breast, and normal bone); however, a consistent linear relationship between 99(m)Tc-P and calcium levels was not observed. A strong correlation (r=0.95 and 0.99, n=2 dogs) was demonstrated between levels of 3H-diphosphonate and 99(m)Tc-P in infarcted myocardium. Autoradiographic studies with 3H-diphosphonate revealed extensive labeling in the infarct periphery which contained necrotic muscle cells with features of severe calcium overloading, including widespread hypercontraction as well as more selective formation of mitochondrial calcific deposits. Autoradiography also demonstrated labeling of a small population of damaged border zone muscle cells which exhibited prominent accumulation of lipid droplets and focal, early mitochondrial calcification. Cell fractionation studies revealed major localization of both 99(m)Tc-P and calcium in the soluble supernate and membrane-debris fractions of infarcted myocardium and less than 2% of total 99(m)Tc-P and calcium in the mitochondrial fractions; however, electron microscopic examination showed that mitochondria with calcific deposits were not preserved in the mitochondrial fractions. In vitro studies evaluating the role of serum protein binding on tissue uptake of 99(m)Tc-P agents demonstrated that, in spite of significant complexing with serum proteins, serum 99(m)Tc-P activity retained the ability to adsorb to calcium hydroxyapatite and amorphous calcium phosphate. In vivo studies showed that concentration of human serum albumin (labeled with iodine-131) in infarcted myocardium reached a maximum of only 3.8 times normal after a circulation time of 96 h, whereas 99(m)Tc-P uptake was at least 10 times normal after a circulation time as short as 1 h. It is concluded that: (a) 99(m)Tc-P uptake in acutely infarcted myocardium, and possibly other types of soft tissue damage, is limited to necrotic and severely injured cell; (b) concentration of 99(m)Tc-P results from selective adsorption of 99(m)Tc-P with various forms of tissue calcium stores, including amorphous calcium phosphate, crystalline hydroxyapatite, and calcium complexed with myofibrils and other macromolecules, possibly supplemented by calcium-independent complexing with organic macromolecules; and (c) lack of linear relationship between 99(m)Tc-P and tissue calcium levels mainly results from local differences in composition and physicochemical properties of tissue calcium stores and from local variations in levels of blood flow for delivery of 99(m)Tc-P agents.

Original languageEnglish (US)
Pages (from-to)724-740
Number of pages17
JournalUnknown Journal
Volume60
Issue number3
DOIs
StatePublished - 1977

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Sites and mechanisms of localization of technetium 99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues'. Together they form a unique fingerprint.

Cite this